Skip to main content
Erschienen in: World Journal of Pediatrics 6/2019

24.07.2019 | Original Article

Association of image-defined risk factors, tumor resectability, and prognosis in children with localized neuroblastoma

verfasst von: An-An Zhang, Ci Pan, Min Xu, Xiao-Xia Wang, Qi-Dong Ye, Yi-Jin Gao, Jing-Yan Tang

Erschienen in: World Journal of Pediatrics | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Although localized neuroblastoma has a good prognosis, some cases have undergone treatment failure or recurrence. Apart from biologic features such as MYCN status, we wondered whether some characteristics of growing tumors are prognostic, such as a well-encapsulated mass without infiltration of vital organs. We analyzed the diagnostic utility of image-defined risk factors (IDRFs) to predict successful treatment and prognosis. The overall goal was to achieve maximum cure rates for patients with localized neuroblastoma through a better understanding of clinical characteristics.

Methods

We retrospectively reviewed the images of patients with localized neuroblastoma who were enrolled between June 1998 and December 2012 at a single institution in Shanghai, China. Unequivocal categorization regarding IDRFs was available in 67 patients. IDRF was assessed at diagnosis and after four cycles of neoadjuvant chemotherapy, on average. The median follow-up period was 84 months (range: 48–132 months) after diagnosis.

Results

MRI and CT indicated a total of 177 IDRFs in these 67 patients. Logistic regression analysis revealed a highly significant negative correlation between the numbers of IDRFs and the possibility of complete removal of neuroblastoma. Intraspinal extension of the tumor, compression of the trachea, and encasement of the main artery in localized neuroblastoma were predictors for incomplete tumor resection. According to univariate analysis, ≥ 4 IDRFs and intraspinal extension of the tumor were significant indicators of poor prognosis.

Conclusions

The number of IDRFs was useful in predicting surgical outcome and event-free survival. The number of IDRFs should be considered in protocol planning, instead of IDRF presence or absence.
Literatur
1.
Zurück zum Zitat Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. Prog Clin Biol Res. 1994;385:363–9.PubMed Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. Prog Clin Biol Res. 1994;385:363–9.PubMed
2.
Zurück zum Zitat Meany HJ, London WB, Ambros PF, Matthay KK, Monclair T, Simmon T, et al. Significance of clinical and biologic features in stage 3 neuroblastoma: a report from the international neuroblastoma risk group project. Pediatr Blood Cancer. 2014;61:1932–9.CrossRef Meany HJ, London WB, Ambros PF, Matthay KK, Monclair T, Simmon T, et al. Significance of clinical and biologic features in stage 3 neuroblastoma: a report from the international neuroblastoma risk group project. Pediatr Blood Cancer. 2014;61:1932–9.CrossRef
3.
Zurück zum Zitat Cohn SL, Pearson ADJ, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force Report. J Clin Oncol. 2009;27:289–97.CrossRef Cohn SL, Pearson ADJ, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force Report. J Clin Oncol. 2009;27:289–97.CrossRef
4.
Zurück zum Zitat Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al. The international neuroblastoma risk Group (INRG) staging system: an INRG Task Force Report. J Clin Oncol. 2009;27:298–303.CrossRef Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al. The international neuroblastoma risk Group (INRG) staging system: an INRG Task Force Report. J Clin Oncol. 2009;27:298–303.CrossRef
5.
Zurück zum Zitat Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology. 2011;261:243–57.CrossRef Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology. 2011;261:243–57.CrossRef
6.
Zurück zum Zitat Cai JY, Tang YJ, Jiang LM, Pan C, Chen J, Tang JY, et al. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem transplantation by CD34+ selection in childhood advanced neuroblastoma. Pediatr Blood Cancer. 2007;49:952–7.CrossRef Cai JY, Tang YJ, Jiang LM, Pan C, Chen J, Tang JY, et al. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem transplantation by CD34+ selection in childhood advanced neuroblastoma. Pediatr Blood Cancer. 2007;49:952–7.CrossRef
7.
Zurück zum Zitat Chen AM, Trout AT, Towbin AJ. A review of neuroblastoma image-defined risk factors on magnetic resonance imaging. Pediatr Radiol. 2018;48:1337–47.CrossRef Chen AM, Trout AT, Towbin AJ. A review of neuroblastoma image-defined risk factors on magnetic resonance imaging. Pediatr Radiol. 2018;48:1337–47.CrossRef
8.
Zurück zum Zitat Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, et al. Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis? Pediatr Surg Int. 2016;32:209–14.CrossRef Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, et al. Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis? Pediatr Surg Int. 2016;32:209–14.CrossRef
9.
Zurück zum Zitat Irtan S, Brisse HJ, Minard-Colin V, Schleiermacher G, Galmiche-Rolland L, Le Cossec C, et al. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection. Pediatr Blood Cancer. 2015;62:1543–9.CrossRef Irtan S, Brisse HJ, Minard-Colin V, Schleiermacher G, Galmiche-Rolland L, Le Cossec C, et al. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection. Pediatr Blood Cancer. 2015;62:1543–9.CrossRef
10.
Zurück zum Zitat Avanzini S, Pio L, Erminio G, Granata C, Holmes K, Gambart M, et al. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes. Pediatr Blood Cancer. 2017;64:e26605.CrossRef Avanzini S, Pio L, Erminio G, Granata C, Holmes K, Gambart M, et al. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes. Pediatr Blood Cancer. 2017;64:e26605.CrossRef
11.
Zurück zum Zitat Fumino S, Kimura K, Iehara T, Nishimura M, Nakamura S, Souzaki R, et al. Validity of image-defined risk factors in localized neuroblastoma: a report from two centers in Western Japan. J Pediatr Surg. 2015;50:2102–6.CrossRef Fumino S, Kimura K, Iehara T, Nishimura M, Nakamura S, Souzaki R, et al. Validity of image-defined risk factors in localized neuroblastoma: a report from two centers in Western Japan. J Pediatr Surg. 2015;50:2102–6.CrossRef
12.
Zurück zum Zitat Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, et al. Can image-defined risk factors predict surgical complications in localized neuroblastoma? Eur J Pediatr Surg. 2016;26:117–22.PubMed Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, et al. Can image-defined risk factors predict surgical complications in localized neuroblastoma? Eur J Pediatr Surg. 2016;26:117–22.PubMed
13.
Zurück zum Zitat Pohl A, Erichsen M, Stehr M, Hubertus J, Bergmann F, Kammer B, et al. Image-defined risk factors correlate with surgical radicality and local recurrence in patients with neuroblastoma. Klin Padiatr. 2016;228:118–23.CrossRef Pohl A, Erichsen M, Stehr M, Hubertus J, Bergmann F, Kammer B, et al. Image-defined risk factors correlate with surgical radicality and local recurrence in patients with neuroblastoma. Klin Padiatr. 2016;228:118–23.CrossRef
14.
Zurück zum Zitat Monclair T, Mosseri V, Cecchetto G, De Bernardi B, Michon J, Holmes K. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group. Pediatr Blood Cancer. 2015;62:1536–42.CrossRef Monclair T, Mosseri V, Cecchetto G, De Bernardi B, Michon J, Holmes K. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group. Pediatr Blood Cancer. 2015;62:1536–42.CrossRef
15.
Zurück zum Zitat Günther P, Holland-Cunz S, Schupp CJ, Stockklausner C, Hinz U, Schenk JP. Significance of image-defined risk factors for surgical complications in patients with abdominal neuroblastoma. Eur J Pediatr Surg. 2011;21:314–7.CrossRef Günther P, Holland-Cunz S, Schupp CJ, Stockklausner C, Hinz U, Schenk JP. Significance of image-defined risk factors for surgical complications in patients with abdominal neuroblastoma. Eur J Pediatr Surg. 2011;21:314–7.CrossRef
16.
Zurück zum Zitat Simon T, Hero B, Benz-Bohm G, von Schweinitz D, Berthold F. Review of image defined risk factors in localized neuroblastoma patients: results of the GPOH NB97 trial. Pediatr Blood Cancer. 2008;50:965–9.CrossRef Simon T, Hero B, Benz-Bohm G, von Schweinitz D, Berthold F. Review of image defined risk factors in localized neuroblastoma patients: results of the GPOH NB97 trial. Pediatr Blood Cancer. 2008;50:965–9.CrossRef
17.
Zurück zum Zitat Irtan S, Brisse HJ, Minard-Colin V, Schleiermacher G, Canale S, Sarnacki S. Minimally invasive surgery of neuroblastic tumors in children: indications depend on anatomical location and image-defined risk factors. Pediatr Blood Cancer. 2015;62:257–61.CrossRef Irtan S, Brisse HJ, Minard-Colin V, Schleiermacher G, Canale S, Sarnacki S. Minimally invasive surgery of neuroblastic tumors in children: indications depend on anatomical location and image-defined risk factors. Pediatr Blood Cancer. 2015;62:257–61.CrossRef
18.
Zurück zum Zitat Warmann SW, Seitz G, Schaefer JF, Scheel-Walter HG, Leuschner I, Fuchs J. Vascular encasement as element of risk stratification in abdominal neuroblastoma. Surg Oncol. 2011;20:231–5.CrossRef Warmann SW, Seitz G, Schaefer JF, Scheel-Walter HG, Leuschner I, Fuchs J. Vascular encasement as element of risk stratification in abdominal neuroblastoma. Surg Oncol. 2011;20:231–5.CrossRef
19.
Zurück zum Zitat Rich BS, McEvoy MP, Kelly NE, Oh E, Abramson SJ, Price AP, et al. Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries. J Pediatr Surg. 2011;46:103–7.CrossRef Rich BS, McEvoy MP, Kelly NE, Oh E, Abramson SJ, Price AP, et al. Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries. J Pediatr Surg. 2011;46:103–7.CrossRef
20.
Zurück zum Zitat Kraal K, Blom T, van Noesel M, Kremer L, Caron H, Tytgat G, et al. Treatment and outcome of neuroblastoma with intraspinal extension: a systematic review. Pediatr Blood Cancer. 2017;64:e26451.CrossRef Kraal K, Blom T, van Noesel M, Kremer L, Caron H, Tytgat G, et al. Treatment and outcome of neuroblastoma with intraspinal extension: a systematic review. Pediatr Blood Cancer. 2017;64:e26451.CrossRef
Metadaten
Titel
Association of image-defined risk factors, tumor resectability, and prognosis in children with localized neuroblastoma
verfasst von
An-An Zhang
Ci Pan
Min Xu
Xiao-Xia Wang
Qi-Dong Ye
Yi-Jin Gao
Jing-Yan Tang
Publikationsdatum
24.07.2019
Verlag
Springer Singapore
Erschienen in
World Journal of Pediatrics / Ausgabe 6/2019
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-019-00274-y

Weitere Artikel der Ausgabe 6/2019

World Journal of Pediatrics 6/2019 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.